Completed
Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours
NCT02171702
- Conditions
- Neoplasms
- Locations
-
Not specified
Clinical trial condition
Neoplasms
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
818 public trials
114 recruiting studies
Neoplasms trial results
NCT02171741
- Conditions
- Neoplasms
- Locations
-
Not specified
NCT02171728
- Conditions
- Neoplasms
- Locations
-
Not specified
NCT00606125
- Conditions
- Neoplasms
- Locations
-
- New Haven, Connecticut, United States
- San Antonio, Texas, United States
NCT01169675
- Conditions
- Neoplasms
- Locations
-
- 1200.92.1001 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada
- 1200.92.1002 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada
NCT00906698
- Conditions
- Neoplasms
- Locations
-
- 1200.69.3301 Boehringer Ingelheim Investigational Site Toulouse, France
- 1200.69.3302 Boehringer Ingelheim Investigational Site Villejuif, France
NCT00264108
- Conditions
- Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- 's-Hertogenbosch, Netherlands
- Amstelveen, Netherlands
- Amsterdam, Netherlands
- Bergen op Zoom, Netherlands
NCT00264095
- Conditions
- Anemia, Blood Loss, Surgical, Hematologic Diseases, +6 more
- Locations
-
- Alkmaar, Netherlands
- Amersfoort, Netherlands
- Apeldoorn, Netherlands
- Deventer, Netherlands
NCT00088114
- Conditions
- Neoplasms
- Locations
-
- Beth Israel-Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT00838370
- Conditions
- Neoplasms
- Locations
-
- Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
- Slotervaart Hospital Amsterdam, Netherlands
- Canisius Wilhelmina Hospital Nijmegen, Netherlands